Texas A&M AgriLife researchers uncovered a promising target for controlling gene expression and other cellular processes, ...

Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...

B.Riley Financial analyst Madison Elsaadi has reiterated their bullish stance on WVE stock, giving a Buy rating on October 31. Madison Elsaadi ...

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision ...

HG202 is the first-ever clinical-stage CRISPR/Cas13 RNA-editing and the only clinical-stage RNA-targeting therapy for nAMD. “This open IND for HG202 by the US FDA – the first regulator to have cleared ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

Neuroblastoma (NB), the most prevalent extracranial solid tumor in children, poses a significant therapeutic challenge due to ...

A study from Kumamoto University reveals that G-quadruplex RNA structures facilitate the aggregation of α-synuclein, a ...

Cancer, a disease with global impact, is intricately linked to dysregulated gene expression, which is influenced by both ...

Oxford Nanopore Technologies observes that direct analysis has already enhanced research across species, disease states, and applications.

Early data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such ...

RNA extraction plays an important role in cancer genetic research. It involves mutation analysis, comparative genomic ...